MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
AKBA — Akebia Therapeutics, Inc.
NasdaqAkebia Therapeutics, Inc.
$0.87
-0.05(-5.33%)
- O
- 0.91
- H
- 0.92
- L
- 0.87
- V
- 4.5M
⏱️ End-of-day dataAs of Oct 1, 2026
AKBA — Latest News & Headlines
6 StoriesAkebia Therapeutics, Inc. (AKBA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Akebia Therapeutics, Inc. (AKBA) Stock Price, News, Quote & History Yahoo! Finance Canada
A new hire's right to buy 8,400 Akebia shares phases in over four years, if they stay. - Stock Titan
A new hire's right to buy 8,400 Akebia shares phases in over four years, if they stay. Stock Titan
Akebia Therapeutics, Inc. (AKBA) stock price, news, quote and history - Yahoo Finance UK
Akebia Therapeutics, Inc. (AKBA) stock price, news, quote and history Yahoo Finance UK
Akebia Therapeutics, Inc. $AKBA Position Reduced by State Street Corp - MarketBeat
Akebia Therapeutics, Inc. $AKBA Position Reduced by State Street Corp MarketBeat
Caesars Entertainment Stock Closes Up 19% On Takeover Buzz - Stocktwits
Caesars Entertainment Stock Closes Up 19% On Takeover Buzz Stocktwits
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) The Manila Times